Search The Medical Knowledge Base
Medical News by Category
Renal Cell Carcinoma News
- Phase III study of Torisel (Pfizer) for Renal Cell Carcinoma does not meet primary endpoint
Published: Wednesday 16 May 2012
- Tivozanib (Astellas) success in
TIVO-1 study for Renal Cell Carcinoma
Published: Wednesday 16 May 2012
- FDA approves Inlyta (Pfizer) for Renal Cell Carcinoma
Published: Saturday 28 January 2012
- FDA Advisory Committee recommends Inlyta (Pfizer) for Renal Cell Carcinoma
Published: Thursday 08 December 2011